2004•Hainan yixueRequires access

Analysis of Effects of Mifepristone in the treatment of myoma of cervix uteri

Zhang Man-hua

Open publisher page 0 citations

Abstract

Objective To investigate the Effects of Mifepristone in the treatment of myoma of cervix uteri. Methods From January 2001 to March 2003, 82 patients with myoma of cervix uteri were treated by Mifepristone. Oral Mifepristone 25 mg was given once every night from the 5th day of menstruation for 30 days, and then oral Mifepristone 12.5mg was given once ever night from day 31 to 90. Treatment repeated every 3 months. All 82 patients were finished 2 cycles. Results Tumor disappearance were found in 19 patients and tumor shrinkage were found in 50 patients. The total respones rate was 84.1%. The average reduction of tumor volume was 44.9%. There were no tumor increasing. No treatment side effects were found. Conclusions Oral Mifepristone is an effective drug in treating myoma of cervix uteri.

About this research paper

What this paper is about

Objective To investigate the Effects of Mifepristone in the treatment of myoma of cervix uteri. Methods From January 2001 to March 2003, 82 patients with myoma of cervix uteri were treated by Mifepristone. Oral Mifepristone 25 mg was given once every night from the 5th day of menstruation for 30 days, and then oral Mifepristone 12.5mg was given once ever night from day 31 to 90. Treatment repeated every 3 months. All 82 patients were finished 2 cycles. Results Tumor disappearance were found in 19 patients and tumor shrinkage were found in 50 patients. The total respones rate was 84.1%. The average reduction of tumor volume was 44.9%. There were no tumor increasing. No treatment side effects were found. Conclusions Oral Mifepristone is an effective drug in treating myoma of cervix uteri.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the Effects of Mifepristone in the treatment of myoma of cervix uteri. Methods From January 2001 to March 2003, 82 patients with myoma of cervix uteri were treated by Mifepristone. Oral Mifepristone 25 mg was given once every night from the 5th day of menstruation for 30 days, and then oral Mifepristone 12.5mg was given once ever night from day 31 to 90. Treatment repeated every 3 months. All 82 patients were finished 2 cycles. Results Tumor disappearance were found in 19 patients and tumor shrinkage were found in 50 patients. The total respones rate was 84.1%. The average reduction of tumor volume was 44.9%. There were no tumor increasing. No treatment side effects were found. Conclusions Oral Mifepristone is an effective drug in treating myoma of cervix uteri.

Key concepts: Mifepristone, Medicine, Cervix, Myoma, Gynecology, Menstruation, Uterus, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of Effects of Mifepristone in the treatment of myoma of cervix uteri — Research Paper | ScholarLens